Literature DB >> 20029240

Genetic and pathogenetic aspects of Noonan syndrome and related disorders.

Martin Zenker1.   

Abstract

Noonan syndrome (NS) and the clinically overlapping disorders cardio-facio-cutaneous syndrome, LEOPARD syndrome, Costello syndrome and Neurofibromatosis-Noonan syndrome share the clinical features of short stature, the same spectrum of congenital heart defects, and a similar pattern of craniofacial anomalies. It is now known that all these disorders are caused by mutations in components of the RAS-MAPK signaling pathway. This pathway was previously known for its involvement in tumorigenesis. This article reviews the current knowledge on underlying genetic alterations and possible pathogenetic mechanisms responsible for NS and related disorders. It discusses the relationship between a group of developmental disorders and oncogenes. Potential future treatment prospects are based on the possibility of inhibiting RAS-MAPK signaling by pharmaceuticals. 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20029240     DOI: 10.1159/000243782

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  16 in total

1.  Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis.

Authors:  Julie E Niemela; Lianghao Lu; Thomas A Fleisher; Joie Davis; Iusta Caminha; Marc Natter; Laurel A Beer; Kennichi C Dowdell; Stefania Pittaluga; Mark Raffeld; V Koneti Rao; João B Oliveira
Journal:  Blood       Date:  2010-11-15       Impact factor: 22.113

Review 2.  Therapeutic targets for neuroblastomas.

Authors:  Garrett M Brodeur; Radhika Iyer; Jamie L Croucher; Tiangang Zhuang; Mayumi Higashi; Venkatadri Kolla
Journal:  Expert Opin Ther Targets       Date:  2014-01-06       Impact factor: 6.902

3.  Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation.

Authors:  Talita M Marin; Kimberly Keith; Benjamin Davies; David A Conner; Prajna Guha; Demetrios Kalaitzidis; Xue Wu; Jessica Lauriol; Bo Wang; Michael Bauer; Roderick Bronson; Kleber G Franchini; Benjamin G Neel; Maria I Kontaridis
Journal:  J Clin Invest       Date:  2011-02-21       Impact factor: 14.808

4.  Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes.

Authors:  Christian P Kratz; Suthee Rapisuwon; Helen Reed; Henrik Hasle; Philip S Rosenberg
Journal:  Am J Med Genet C Semin Med Genet       Date:  2011-04-15       Impact factor: 3.908

5.  Clinical and Molecular Findings of Tunisian Patients with RASopathies.

Authors:  Rim Louati; N Bouayed Abdelmoula; Imen Trabelsi; Dorra Abid; Christina Lissewski; Najla Kharrat; Samir Kamoun; Martin Zenker; Tarek Rebai
Journal:  Mol Syndromol       Date:  2014-05-23

Review 6.  The differential diagnosis of familial lentiginosis syndromes.

Authors:  Maya B Lodish; Constantine A Stratakis
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

7.  Investigation of cardiomyopathy using cardiac magnetic resonance imaging part 2: Rare phenotypes.

Authors:  Ailbhe C O'Neill; Shaunagh McDermott; Carole A Ridge; David Keane; Jonathan D Dodd
Journal:  World J Cardiol       Date:  2012-05-26

8.  Germline PTPN11 and somatic PIK3CA variant in a boy with megalencephaly-capillary malformation syndrome (MCAP)--pure coincidence?

Authors:  Dennis Döcker; Max Schubach; Moritz Menzel; Christiane Spaich; Heinz-Dieter Gabriel; Martin Zenker; Deborah Bartholdi; Saskia Biskup
Journal:  Eur J Hum Genet       Date:  2014-06-18       Impact factor: 4.246

Review 9.  A review of craniofacial and dental findings of the RASopathies.

Authors:  H Cao; N Alrejaye; O D Klein; A F Goodwin; S Oberoi
Journal:  Orthod Craniofac Res       Date:  2017-06       Impact factor: 1.826

Review 10.  From Bench to Bedside and Back: Improving Diagnosis and Treatment of Craniofacial Malformations Utilizing Animal Models.

Authors:  Alice F Goodwin; Rebecca Kim; Jeffrey O Bush; Ophir D Klein
Journal:  Curr Top Dev Biol       Date:  2015-10-06       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.